🚧 Under construction — VoTechWorks is being built. A free tech program — complimentary, as our commitment to get America working.
voTechWorksGrade 13 · a vocational technology learning center, by urbanicity
newSchoolWorks.com › VoTechWorks › Health & Personal Services › Pharmacy Technician › Compounding: Non-Sterile, Sterile and Hazardous (USP <795>, <797>, <800>) › Lesson 3
HLT-PHAR41-04 · Lesson 3 · 15 clock hours · lab

Non-sterile preparations: solutions, suspensions, ointments, creams, capsules

Objective. Prepare the common non-sterile dosage forms to a master formulation record and assign a beyond-use date under USP <795>.

⚠ Pending professional review

This lesson, its worked examples and its practice questions has not yet been verified by a licensed pharmacist or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.

VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.

What Is Non-Sterile Compounding?

Non-sterile compounding means preparing a customized medication that does not need to be free of all microorganisms. Common examples include oral suspensions, topical ointments and creams, and hand-filled capsules. A licensed pharmacist supervises every step; the pharmacy technician follows the master formulation record (MFR) exactly and documents each preparation on a compounding record. USP Chapter <795> sets the minimum standards for non-sterile preparations in the United States.

USP <795> Key Requirements

USP <795> covers personnel, facilities, equipment, ingredients, packaging, and quality checks. Key points you must know:

The Master Formulation Record

The MFR is the official recipe. It lists every ingredient with its quantity, the equipment needed, the step-by-step procedure, quality checks, packaging requirements, storage conditions, and the beyond-use date (BUD) calculation method. You must follow the MFR exactly. Any deviation must be reported to the pharmacist immediately.

Beyond-Use Dates Under USP <795>

A BUD is the date after which a compounded preparation should not be used. It is not the same as a manufacturer's expiration date. USP <795> provides default BUD limits based on the category of the preparation and the container and storage conditions. The pharmacist assigns the BUD; the technician must record it accurately on the label.

Default BUD categories under USP <795> (current guidance — always confirm against the active edition):

These defaults apply unless stability data support a longer dating. The pharmacist makes the final determination.

Preparing an Oral Suspension

An oral suspension contains solid particles distributed throughout a liquid. Because particles settle, the label must say "Shake Well Before Use." General steps:

1. Verify the MFR and gather all ingredients and equipment.

2. Calculate and weigh or measure each ingredient accurately.

3. If using a powder, triturate (grind) it to a fine, uniform particle size in a mortar.

4. Add a small volume of the suspending vehicle and mix to form a smooth paste (levigation).

5. Gradually add the remaining vehicle with constant mixing until the target volume is reached.

6. Transfer to the dispensing container and label with BUD and storage instructions.

Preparing a Topical Ointment

An ointment is a semisolid preparation intended for skin application. It typically contains an oleaginous (oil-based) base such as white petrolatum. Steps:

1. Verify the MFR.

2. If the active drug is a powder, reduce particle size by triturating on an ointment slab or in a mortar.

3. Use geometric dilution: mix the smallest quantity first, then add equal amounts of base progressively.

4. Incorporate the remaining base until the product is smooth and uniform.

5. Transfer to the dispensing jar or tube and label with BUD and storage conditions.

6. Inspect for uniformity of color and texture before presenting to the pharmacist.

Filling Capsules by Hand

Hard-gelatin capsules are filled with a powder blend. A capsule machine speeds up the process and helps ensure uniform fill weight. Key steps:

1. Verify the MFR and check capsule size (000 is largest, 5 is smallest; size 0 and 1 are most common for adults).

2. Weigh all powders individually; do not estimate.

3. Mix powders using geometric dilution to ensure uniformity.

4. Load capsule bodies into the machine, fill with the powder blend, and tamp gently to consistent density.

5. Cap each capsule, remove from the machine, and wipe clean.

6. Weight check: weigh a sample of filled capsules; compare to the target weight from the MFR. Record results.

7. Present to pharmacist for verification.

Safety Points

Key terms8

Master Formulation Record (MFR)The official written recipe for a compounded preparation, listing ingredients, quantities, equipment, procedure, quality checks, packaging, storage, and BUD calculation.
Beyond-Use Date (BUD)The date after which a compounded preparation must not be used; assigned by the pharmacist based on USP <795> guidelines and ingredient stability data.
USP <795>The United States Pharmacopeia chapter that establishes standards for non-sterile compounding, including personnel, environment, ingredients, and BUD limits.
Geometric DilutionA mixing technique in which the ingredient present in the smallest amount is mixed with an approximately equal volume of a second ingredient, then that mixture is combined with another equal portion, and so on, until all ingredients are incorporated uniformly.
LevigationThe process of reducing particle size and incorporating a powder into a small amount of liquid or base to form a smooth paste before adding the remaining vehicle.
TriturationGrinding a solid to a fine, uniform powder using a mortar and pestle; used to reduce particle size for suspensions or powder blends.
Compounding RecordThe batch-specific document completed in real time during preparation, recording actual quantities used, lot numbers, initials, and any deviations from the MFR.
Suspending VehicleA liquid base that keeps solid particles distributed throughout an oral suspension; examples include commercially prepared suspending agents or simple syrup blends.

Worked examples4

1. The MFR calls for preparing 150 mL of an oral suspension. The formula requires 2 g of drug powder per 100 mL of finished suspension. How many grams of powder are needed for 150 mL?
  1. Identify the concentration from the MFR: 2 g per 100 mL.
  2. Set up a proportion: 2 g / 100 mL = x g / 150 mL.
  3. Solve for x: x = (2 g × 150 mL) / 100 mL = 300 / 100 = 3 g.
Answer: 3 g of drug powder is needed.
2. You are filling capsules. The MFR states each capsule should contain 250 mg of active ingredient plus 50 mg of lactose filler, for a total fill weight of 300 mg per capsule. You need to prepare 30 capsules. How many grams of active ingredient and how many grams of lactose do you weigh out in total?
  1. Calculate total active ingredient: 250 mg × 30 capsules = 7,500 mg.
  2. Convert to grams: 7,500 mg ÷ 1,000 = 7.5 g of active ingredient.
  3. Calculate total lactose: 50 mg × 30 capsules = 1,500 mg.
  4. Convert to grams: 1,500 mg ÷ 1,000 = 1.5 g of lactose.
Answer: Weigh 7.5 g of active ingredient and 1.5 g of lactose.
3. You prepare a water-containing topical cream on March 3. The pharmacist stores it under refrigeration. Using the USP <795> default BUD for an aqueous topical preparation stored refrigerated, what is the latest acceptable BUD?
  1. Identify the preparation category: aqueous topical preparation.
  2. Identify storage condition: refrigerated.
  3. Apply the USP <795> default: up to 35 days for aqueous topical preparations stored refrigerated.
  4. Count 35 days from March 3: March has 31 days, so March 3 + 28 days remaining in March = March 31, then 7 more days = April 7.
Answer: The latest BUD is April 7 (35 days from March 3).
4. A filled capsule should weigh 400 mg. After filling, you weigh three capsules and get 395 mg, 408 mg, and 402 mg. What is the average fill weight, and is the batch within ±5% of the target?
  1. Add the three weights: 395 + 408 + 402 = 1,205 mg.
  2. Divide by 3 to find the average: 1,205 ÷ 3 ≈ 401.7 mg.
  3. Calculate 5% of the target weight: 400 mg × 0.05 = 20 mg.
  4. Acceptable range: 400 − 20 = 380 mg to 400 + 20 = 420 mg.
  5. Check each individual capsule: 395, 408, and 402 all fall within 380–420 mg.
  6. The average (≈ 401.7 mg) also falls within the range.
Answer: Average fill weight ≈ 401.7 mg; all three capsules and the average are within the ±5% acceptable range (380–420 mg).

The math in this lesson1

Learners scale 2 g per 100 mL to find 3 g of drug powder for 150 mL of suspension.
7.RP.2
In class: Oral suspension · Topical ointment · Hand-filled capsules
Materials: Ingredients, capsule machine, master formulation records
Check: Product meets record; BUD correct

Practice check8

Answer each question, then check it. Nothing is recorded; this is your own practice.

Patient Safety and Quality Assurance
1. Which document must a pharmacy technician follow exactly when preparing a compounded non-sterile product?
Patient Safety and Quality Assurance
2. Under USP <795> default guidelines, what is the maximum beyond-use date for a compounded aqueous oral suspension stored under refrigeration?
Patient Safety and Quality Assurance
3. A pharmacy technician notices while compounding that the amount of active ingredient weighed out is less than what the master formulation record specifies. What should the technician do first?
Medications
4. When incorporating a small quantity of a potent powder into a large amount of ointment base, which technique ensures the most uniform distribution?
Medications
5. Which auxiliary label is required on every compounded oral suspension?
Medications
6. Hard-gelatin capsule sizes are numbered from 000 (largest) to 5 (smallest). Which size is most commonly used for standard adult oral dosage forms?
Patient Safety and Quality Assurance
7. A technician is preparing a compounded nonaqueous ointment. The earliest expiration date among all ingredients is 90 days from today. The USP <795> default BUD for nonaqueous preparations is up to 180 days. What BUD should be assigned?
Federal Requirements
8. Which of the following best describes the pharmacy technician's role at the conclusion of any non-sterile compounding session?
Record this lesson on my transcript. Sign in with your key and enrollment email to record lessons (enroll free if you have no key). This page stays open to read and practise.